VA
Vaishali Pharma Limited
VAISHALI.NS · NSE
₹8.32 -0.48% (-₹0.04)
1M +5.58%
Market Cap ₹898.3M
P/E Ratio 20.99x
Div. Yield -
ROE 6.37%
Piotroski F-Score Weak
2/9Valuation
55 /100
Fair P/E 20.99x
EV/EBITDA 21.16x
P/S 0.83x
Growth
58 /100
Stable EPS growth 481.86%
Rev. growth 6.05%
FCF growth 37.25%
Profitability
13 /100
Weak Gross margin 9.21%
Net margin 3.97%
Op. margin 3.37%
Quality
30 /100
Poor ROIC 3.15%
ROE 6.37%
ROA 3.47%
Debt
63 /100
Moderate Debt/Equity 0.27x
Current ratio 2.34x
Int. coverage 2.45x
Stability
36 /100
Moderate Beta 0.37x
Rev. volatility 28.31%
EPS volatility 1,753.02%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o VAISHALI.NS
Online
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Hemanth Damodar Pathak
Employees
27
Headquarters
Mumbai